Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
Oncogene. 2010 Jun 3;29(22):3252-62. doi: 10.1038/onc.2010.84. Epub 2010 Mar 29.
T-box 2 (TBX2) is a transcription factor involved in mammary development and is known to be overexpressed in a subset of aggressive breast cancers. TBX2 has previously been shown to repress growth control genes such as p14(ARF) and p21(WAF1/cip1). In this study we show that TBX2 drives proliferation in breast cancer cells and this is abrogated after TBX2 small interfering RNA (siRNA) knockdown or after the expression of a dominant-negative TBX2 protein. Using microarray analysis we identified a large cohort of novel TBX2-repressed target genes including the breast tumour suppressor NDRG1 (N-myc downregulated gene 1). We show that TBX2 targets NDRG1 through a previously undescribed mechanism involving the recruitment of early growth response 1 (EGR1). We show EGR1 is required for the ability of TBX2 to repress NDRG1 and drive cell proliferation. We show that TBX2 interacts with EGR1 and that TBX2 requires EGR1 to target the NDRG1 proximal promoter. Abrogation of either TBX2 or EGR1 expression is accompanied by the upregulation of cell senescence and apoptotic markers. NDRG1 can recapitulate these effects when transfected into TBX2-expressing cells. Together, these data identify a novel mechanism for TBX2-driven oncogenesis and highlight the importance of NDRG1 as a growth control gene in breast tissue.
T 盒转录因子 2(TBX2)是一种参与乳腺发育的转录因子,已知在一部分侵袭性乳腺癌中过度表达。TBX2 先前被证明可以抑制如 p14(ARF) 和 p21(WAF1/cip1) 等生长控制基因的表达。在这项研究中,我们发现 TBX2 驱动乳腺癌细胞的增殖,而这种作用在 TBX2 小干扰 RNA(siRNA)敲低或表达显性负 TBX2 蛋白后被消除。通过微阵列分析,我们鉴定了一大群新的 TBX2 抑制的靶基因,包括乳腺癌肿瘤抑制因子 NDRG1(N-myc 下调基因 1)。我们发现 TBX2 通过一种以前未描述的机制靶向 NDRG1,该机制涉及早期生长反应因子 1(EGR1)的募集。我们表明 EGR1 是 TBX2 抑制 NDRG1 和驱动细胞增殖的能力所必需的。我们发现 TBX2 与 EGR1 相互作用,并且 TBX2 需要 EGR1 来靶向 NDRG1 近端启动子。TBX2 或 EGR1 表达的缺失伴随着细胞衰老和凋亡标志物的上调。当转染到表达 TBX2 的细胞中时,NDRG1 可以再现这些效应。这些数据共同确定了 TBX2 驱动肿瘤发生的新机制,并强调了 NDRG1 作为乳腺组织中生长控制基因的重要性。